Comparison and trend analysis of cancer incidence in China and globally in 2022

Table 2 Cancer incidence by sex in China and globally in 2022

Cancer sites	ICD-10	Chinese cancer incidence				Global cancer incidence
		Rank	Males cases (× 104)	Rank	Females cases (× 104)	Rank	Males cases (× 104)	Rank	Females cases (× 104)
Lung	C33–34	1	65.87	1	40.19	1	157.19	2	90.84
Colon-rectum	C18–21	2	30.77	4	20.94	3	106.93	3	85.68
Liver	C22	3	26.79	7	9.98	5	60.02	10	26.50
Stomach	C16	4	24.66	6	11.21	4	62.72	7	34.11
Esophagus	C15	5	16.75	10	5.65	8	36.50	17	14.57
Prostate	C61	6	13.42	–	–	2	146.67	–	–
Thyroid	C73	7	12.49	3	34.12	13	20.65	5	61.47
Bladder	C67	8	7.32	16	1.97	6	47.11	18	14.27
Pancreas	C25	9	6.71	11	5.15	12	26.96	11	24.10
Lymphoma	C81–86, 88	10	4.81	13	3.71	9	35.99	9	27.55
Kidney	C64	11	4.73	15	2.64	11	27.76	14	15.68
Leukemia	C91–95	12	4.70	14	3.50	10	27.78	12	20.90
Lip, oral cavity & pharynx	C00–10, 12–13	13	4.56	17	1.95	7	45.80	13	17.90
Brain, central nervous system	C70–72	14	4.24	12	4.51	15	17.36	16	14.79
Nasopharynx	C11	15	3.67	19	1.44	17	8.63	20	3.42
Larynx	C32	16	2.72	21	0.23	16	16.56	21	2.34
Gallbladder	C23	17	1.27	18	1.85	19	4.35	19	7.89
Melanoma of skin	C43	18	0.44	20	0.44	14	17.99	15	15.17
Testis	C62	19	0.35	–	–	18	7.20	–	–
Female breast	C50	–	–	2	35.72	–	–	1	229.57
Cervix	C53	–	–	5	15.07	–	–	4	66.10
Uterus	C54	–	–	8	7.77	–	–	6	42.02
Ovary	C56	–	–	9	6.11	–	–	8	32.44
All other sites1	Other		16.73		14.96		156.47		118.51
All sites1	All		253.39		229.08		1030.65		965.84

¹Non-melanoma skin cancer (C44) was included.

ICD-10: International Statistical Classification of Diseases and Related Health Problems 10^th Revision.